NDC 11098-030-05 - SUBLIMAZE
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 11098-030
- Requested NDC
- 11098-030-05
- Package NDCs from labels
- 11098-030-02, 11098-030-05, 11098-030-10, 11098-030-20
- Manufacturer
- Taylor Pharmaceuticals
- Effective date
- 2008-04-21
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| SUBLIMAZE - Taylor Pharmaceuticals | Taylor Pharmaceuticals | 2008-04-21 | HUMAN PRESCRIPTION DRUG LABELING |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| fentanyl citrate | ACTIVE INGREDIENT | MUN5LYG46H | SUBLIMAZE (FENTANYL CITRATE) INJECTION, SOLUTION [TAYLOR PHARMACEUTICALS] | 1 | |
| fentanyl | ACTIVE MOIETY | UF599785JZ | SUBLIMAZE (FENTANYL CITRATE) INJECTION, SOLUTION [TAYLOR PHARMACEUTICALS] | 1 | |
| sodium hydroxide | INACTIVE INGREDIENT | 55X04QC32I | SUBLIMAZE (FENTANYL CITRATE) INJECTION, SOLUTION [TAYLOR PHARMACEUTICALS] | 1 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| E7FCE1EB-443E-B5AA-4E29-5E8376E4D05A | 8944EA18-016E-4971-876D-2365FAC190EA | 2008-04-21 | Warnings, Adverse reactions | E7FCE1EB-443E-B5AA-4E29-5E8376E4D05A 8944EA18-016E-4971-876D-2365FAC190EA |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.